Some pharmacological applications of an extracellular recording method to study secretion of a sympathetic co-transmitter, presumably ATP

The purinergic neurotransmitter revisited: a single substance or multiple players?

The past half century has witnessed tremendous advances in our understanding of extracellular purinergic signaling pathways. Purinergic neurotransmission, in particular, has emerged as a key contributor in the efficient control mechanisms in the nervous system. The identity of the purine neurotransmitter, however, remains controversial. Identifying it is difficult because purines are present in all cell types, have a large variety of cell sources, and are released via numerous pathways. Moreover, studies on purinergic neurotransmission have relied heavily on indirect measurements of integrated postjunctional responses that do not provide direct information for neurotransmitter identity. This paper discusses experimental support for adenosine 5'-triphosphate (ATP) as a neurotransmitter and recent evidence for possible contribution of other purines, in addition to or instead of ATP, in chemical neurotransmission in the peripheral, enteric and central nervous systems. Sites of release and action of purines in model systems such as vas deferens, blood vessels, urinary bladder and chromaffin cells are discussed. This is preceded by a brief discussion of studies demonstrating storage of purines in synaptic vesicles. We examine recent evidence for cell type targets (e.g., smooth muscle cells, interstitial cells, neurons and glia) for purine neurotransmitters in different systems. This is followed by brief discussion of mechanisms of terminating the action of purine neurotransmitters, including extracellular nucleotide hydrolysis and possible salvage and reuptake in the cell. The significance of direct neurotransmitter release measurements is highlighted. Possibilities for involvement of multiple purines (e.g., ATP, ADP, NAD(+), ADP-ribose, adenosine, and diadenosine polyphosphates) in neurotransmission are considered throughout.

Characterization of action potential-evoked calcium transients in mouse postganglionic sympathetic axon bundles

1. Action potential-evoked Ca(2+) transients in postganglionic sympathetic axon bundles in mouse vas deferens have been characterized using confocal microscopy and Ca(2+) imaging. 2. Axonal Ca(2+) transients were tetrodotoxin sensitive. The amplitude depended on both the frequency of stimulation and the number of stimuli in a train. 3. Removal of extracellular Ca(2+) abolished the Ca(2+) transient. Cd(2+)(100 microM) inhibited the Ca(2+) transient by 78 +/- 10 %. The N-type Ca(2+) channel blocker omega-conotoxin GVIA (0.1 microM) reduced the amplitude by -35 +/-4 %, whereas nifedipine (10 microM; L-type) and omega-conotoxin MVIIC (0.1 microM; P/Q type) were ineffective. 4. Caffeine (10 mM), ryanodine (10 microM), cyclopiazonic acid (30 microM) or CCCP (10 microM) had no detectable effects. 5. Blockade of large and small conductance Ca(2+)-dependent K+ channels with iberiotoxin (0.1 microM) and apamin (1 microM), respectively, or Ca(2+)-dependent Cl(-) channels by niflumic acid (100 microM) did not alter Ca(2+) transients. 6. In contrast, the non-specific K+ channel blockers tetraethylammonium (10 mM) and 4-aminopyridine (10 mM) markedly increased the amplitude of the Ca(2+) transient. Blockade of delayed rectifiers and A-like K+ channels, by tityustoxin-K (alpha) (0.1 microM) and pandinustoxin-K (alpha) (10 nM), respectively, also increased the Ca(2+) transient amplitude. 7. Thus, Ca(2+) transients are evoked by Na(+)-dependent action potentials in axons. These transients originate mainly from Ca(2+) entry through voltage-dependent Ca(2+) channels (80 % Cd(2+) sensitive of which 40 % was attributable to N-type). Twenty per cent of the Ca(2+) transient was not due to Ca(2+) entry through voltage-gated Ca(2+) channels. Intracellular stores and mitochondria were not involved in the generation of the transient. Ca(2+) transients are modulated by A-like K+ channels and delayed rectifiers (possibly K(V)1.2) but not by Ca(2+)-activated ion channels.

Neurotransmitter release mechanisms in sympathetic neurons: past, present, and future perspectives

In 1969, Paton and Vizi described the inhibitory actions of noradrenaline on acetylcholine release from the innervation of the guinea-pig ileum longitudinal muscle. They concluded "that acetylcholine output by the nervous networks of the longitudinal strip is under the normal control of the sympathetic by a species of presynaptic inhibition mediated by <==> receptors". This work was carried out in the Pharmacology Department at Oxford University. Clearly, a period in the 'Dreaming Spires' of Oxford sufficiently inspired Sylvester to take up a life long career in scientific research. He has published more than 300 papers on a wide range of topics but clearly has a strong interest in neurotransmitter release mechanisms and recently, non-synaptic interactions between neurons. It seems fitting therefore to write a brief review on the continuing studies on neurotransmitter release mechanisms in sympathetic neurons in a volume honoring the now distinguished Professor Vizi.

Ion channels in presynaptic nerve terminals and control of transmitter release

The primary function of the presynaptic nerve terminal is to release transmitter quanta and thus activate the postsynaptic target cell. In almost every step leading to the release of transmitter quanta, there is a substantial involvement of ion channels. In this review, the multitude of ion channels in the presynaptic terminal are surveyed. There are at least 12 different major categories of ion channels representing several tens of different ion channel types; the number of different ion channel molecules at presynaptic nerve terminals is many hundreds. We describe the different ion channel molecules at the surface membrane and inside the nerve terminal in the context of their possible role in the process of transmitter release. Frequently, a number of different ion channel molecules, with the same basic function, are present at the same nerve terminal. This is especially evident in the cases of calcium channels and potassium channels. This abundance of ion channels allows for a physiological and pharmacological fine tuning of the process of transmitter release and thus of synaptic transmission.

Autonomic neuromuscular transmission at a varicosity

This review attempts to clarify the definition of what constitutes an autonomic neuromuscular function formed by a varicosity. Ultrastructural studies of serial sections through varicosities, partly or wholly bare of Schwann cell covering, show that areas of close apposition occur between varicosities and muscle cell membrane that vary between 20 and 150 nm, depending on the muscle considered. Consideration of the diffusion of purine transmitters and their receptor kinetics after secretion in a packet show that the number of purinergic receptor channels opened at a site of 150 nm apposition by a varicosity is about 15% of that at a site of 50 nm apposition. These results, together with the analysis of the stochastic fast component and the deterministic slow components of the rising phase of the EJP suggest that the stochastic fast component is due to varicosities that form especially close appositions (20-50 nm), whereas the deterministic slow component is due to the large number of varicosities at distances up to about 150 nm. Varicosities forming appositions of 20-150 nm with muscle cells several hundred micrometers long possess junctional receptor types distinct from extrajunctional receptors. According to this argument, then, there are two different classes of varicosities: one that gives rise to a relatively large junctional current and another that is responsible for a very small junctional current. Present evidence suggests that two subclasses of varicosities can be discerned amongst the varicosities that generate large junctional currents. One of these subclasses of varicosity possesses relatively few post-junctional receptors compared with the amount of transmitter reaching the receptors from the varicosity, so that the junctional current generated is determined by the size of the receptor population; in this case, the size of the transmitter packages released from these varicosities is unknown and the size of the junctional current is relatively constant. The other subclass of varicosity possesses large receptor patches, sufficient to accommodate the largest amounts of transmitter released from the varicosities: in this case, the size of the transmitter packages is shown to be highly non-uniform. These speculations await confirmation by direct labelling of the receptor patches beneath varicosities, a possibility that is likely to be realized in the near future.

Effect of morphine on the nerve terminal impulse and transmitter release from sympathetic varicosities innervating the mouse vas deferens

1 The effect of morphine on both the propagation of the nerve terminal impulse along the sympathetic varicose axons as well as the evoked and spontaneous transmitter release has been evaluated. 2 Morphine (1 microM) did not significantly change the shape or the regularity by which the nerve terminal impulse was recorded while evoked transmitter release was greatly reduced. 3 Morphine induced a uniform decrease in evoked transmitter release irrespective of the release probability of individual varicosities of their position along terminal branches. 4 Procedures which are thought to increase intracellular calcium concentration such as increasing the extracellular calcium concentration, stimulation of the nerve with trains of impulses and increasing the duration of the action potential with 4-aminopyridine reduced the ability of morphine to decrease evoked transmitter release. 5 Morphine had to act directly on the varicosities to induce a decrease in evoked transmitter release. 6 The decrease in evoked quantal release does not involve an affect on the nerve terminal impulse or the vesicle release process and morphine may affect the dependence of the secretory process on calcium.

Geometry, kinetics and plasticity of release and clearance of ATP and noradrenaline as sympathetic cotransmitters: roles for the neurogenic contraction

The paper compares the microphysiology of sympathetic neuromuscular transmission in three model preparations: the guinea-pig and mouse vas deferens and rat tail artery. The first section describes the quantal release of ATP and noradrenaline from individual sites. The data are proposed to support a string model in which: (i) most sites (> or = 99%) ignore the nerve impulse and a few (< or = 1%) release a single quantum of ATP and noradrenaline; (ii) the probability of monoquantal release is extremely non-uniform; (iii) high probability varicosities form 'active' strings; and (iv) an impulse train causes repeated quantal release from these sites. Analogy with molecular mechanisms regulating transmitter exocytosis in other systems is proposed to imply that coincidence of at least two factors at the active zone, Ca2+ and specific cytosolic protein(s), may be required to remove a 'fusion clamp', form a 'fusion complex' and trigger exocytosis of a sympathetic transmitter quantum, and that the availability of these proteins may regulate the release probability. The second section shows that clearance of noradrenaline in rat tail artery is basically > or = 30-fold slower than of co-released ATP, and that saturation of local reuptake and binding to local buffering sites maintain the noradrenaline concentration at the receptors, in spite of a profound decline in per pulse release during high frequency trains. The third section describes differences in the strategies by which mouse vas deferens and rat tail artery use ATP and noradrenaline to trigger and maintain the neurogenic contraction.

A calcium-dependent component of the action potential in sympathetic nerve terminals in rat tail artery

A pharmacological approach was employed in order to visualize a Ca2(+)-dependent component of the extracellularly recorded nerve terminal impulse in the secretory regions of the sympathetic postganglionic nerves in the rat tail artery. Application of potassium-channel-blocking agents within the recording electrode caused the nerve terminal impulse to acquire a delayed negative deflection, which we have termed the late negative component (LNC) of the nerve terminal impulse. The time course and the latency of the LNC differed from that of the postjunctional transmitter-induced excitatory junction current, and the LNC persisted when the excitatory junction current was blocked by adenosine [alpha,beta-methylene]triphosphate, and was resistant to the alpha 1-antagonist prazosin and the alpha 2-antagonist yohimbine. Probably, therefore, the LNC was exclusively prejunctional in origin. For the following reasons it seems likely that the LNC, at least in part, was caused by influx of Ca2+ into the secretory regions of these nerves: (a) the LNC occurred only when potassium-blocking agents were present within the recording electrode; (b) the LNC amplitude increased with the Ca2+ concentration inside the recording electrode and was reduced by the removal of Ca2+; (c) the LNC was enhanced by replacing Ca2+ in the medium inside the recording electrode with Ba2+; (d) the LNC was depressed by the inorganic Ca2(+)-channel blocker cadmium or the Ca2(+)-channel-blocking peptide omega-conotoxin added within the recording electrode only, or by addition of cadmium or cobalt (but not the organic Ca2(+)-channel blocker nifedipine) inside and outside the recording electrode.(ABSTRACT TRUNCATED AT 250 WORDS)

K+ and Ca2+ channel blockers may enhance or depress sympathetic transmitter release via a Ca(2+)-dependent mechanism "upstream" of the release site

Extracellular recording of the pre- and postjunctional electrical activity in guinea-pig or mouse vas deferens or rat tail artery was employed to study the mechanisms by which the K+ channel blockers, tetraethylammonium and 4-aminopyridine and the Ca2+ channel blockers, Cd2+, Mn2+ or nifedipine influence the nerve stimulation-induced release of adenosine 5'-triphosphate as a sympathetic co-transmitter. The K+ and Ca2+ channel blocking agents examined had no effect on the spontaneous quantal release of adenosine 5'-triphosphate. However, addition of tetraethylammonium and 4-aminopyridine inside the recording electrode broadened the nerve terminal action potential and caused it to become more resistant to local application of tetrodotoxin, and dramatically increased the magnitude and tetrodotoxin resistance of adenosine 5'-triphosphate release within the patch. Surprisingly, tetraethylammonium and 4-aminopyridine were equally effective when added outside the recording electrode; now they did not increase the duration of the nerve terminal action potential inside the patch but increased its resistance to locally applied tetrodotoxin and dramatically increased the magnitude as well as the tetrodotoxin resistance of adenosine 5'-triphosphate release from sites inside the patch. Both tetraethylammonium and 4-aminopyridine contributed to these effects, with a strong potentiating interaction. Nifedipine was without effect, but application of 1-100 microM Cd2+ or 1-5 mM Mn2+ either inside or outside the recording electrode blocked adenosine 5'-triphosphate release inside the patch. The results indicate: (i) that the nerve terminal action potential is generated by activation of voltage-gated, regenerative Na+ channels but also has a small component carried by influx of Ca2+ and that it is "normally" terminated by activation of voltage- as well as Ca(2+)-dependent K+ channels; (ii) that the release probability is tonically depressed by the resting K+ efflux, and promoted by the resting Ca2+ influx, "upstream" of the release sites; and (iii) that the upstream control of the release probability may involve both changes in properties of ionic channels in the nerve terminal membrane, and effects on the cytoskeleton leading to changes in the availability of releasable quanta in varicosities within the patch.

Dual control of local blood flow by purines

The potent and widespread vascular actions of purine nucleotides and nucleosides have long been recognized. A dual function for ATP in the regulation of vascular tone is considered. ATP acts as an excitatory cotransmitter with noradrenaline from sympathetic perivascular nerves, to cause vasoconstriction via P2X-purinoceptors located on vascular smooth muscle. In contrast, ATP can act via P2Y-purinoceptors located on vascular endothelial cells to release EDRF, which diffuses to the vascular smooth muscle and produces vasodilatation. The main source of intraluminal ATP is likely to be endothelial cells, and its release can be measured during conditions such as changes in flow and hypoxia, in amounts sufficient to activate endothelial P2Y-purinoceptors. In some vessels, ATP acts directly on P2Y-purinoceptors located in the vascular smooth muscle to produce vasodilatation; the possibility that the origins of this ATP are nonsympathetic purinergic or sensory-motor nerves is discussed. ATP can also be released during intravascular platelet aggregation and from intact and damaged vascular smooth muscle cells, and so may play a role in the complex physiological mechanisms controlling local vascular tone under normoxic conditions, during changes in blood flow and during vessel injury.

Presynaptic receptors and modulation of noradrenaline and ATP secretion from sympathetic nerve varicosities

Our results in the model tissues examined show (1) that alpha 2 agonist(s) depressed the secretion of NA and ATP caused by nerve stimulation at low frequency, (2) that the secretion of both NA and ATP was moderately autoinhibited, under conditions when endogenous NA was shown to accumulate extracellularly, (3) that a K+ channel blocking agent increased much more strongly than alpha 2-adrenoceptors block the secretion of both NA and ATP, and also amplified enormously the NA-mediated neurogenic contraction, (4) that, therefore, a high K+ efflux is likely to be much more important than alpha 2-adrenoceptor-mediated autoinhibition for maintaining a low release probability in sympathetic nerve varicosities, and (5) that the alpha 2-adrenoceptor agonist, clonidine, or the Ca2+ channel blocking agent, Cd2+, inhibited transmitter secretion, at least in part, via targets "upstream" of the varicosity.

Sympathetic transmission in small mesenteric arteries from the rat: influence of impulse pattern

We have previously studied the transmitters involved in, and the calcium dependency of, the neurogenic response to continuous, regular nerve stimulation in small mesenteric arteries from the rat. We have now studied responses to irregular nerve stimulation in these respects. Small mesenteric arteries from rat were mounted into a myograph and the intramural sympathetic nerves were activated by field stimulation. Irregular nerve stimulation was patterned after recorded activity in human cutaneous nerves. The response to irregular stimulation was reduced by only approximately 50% in the presence of the alpha 1-adrenoceptor antagonist prazosin. In particular, responses to low-frequency stimulation were resistant to prazosin. When the extracellular calcium concentration was reduced from 2.5 to 1.0 mM, approximately 50% of the response to irregular nerve stimulation remained. Responses to low-frequency stimulation were particularly reduced. Thus in these arteries the neurogenic response is caused by noradrenaline and a, perhaps purinergic, co-transmitter. The co-transmitter is important for the response to low-frequency stimulation and for the initial part of the contraction caused by high-frequency stimulation. Reducing the calcium concentration affects more strongly the response to low-frequency nerve stimulation.

"Upstream" regulation of the release probability in sympathetic nerve varicosities

The results appear to support the following tentative working hypothesis. (1) Nerve impulse-induced transmitter release from sympathetic nerve varicosities is monoquantal and highly intermittent (probability range: 0-0.03). (2) Nerve impulses invade varicosities as all-or-none, Na+ channel-dependent action potentials; invasion failure may be rare. (3) The release probability is not controlled by properties (amplitude or duration) of the invading action potential or the resulting Ca2+ current, but by the availability of an as yet unidentified permissive factor. (4) The permissive factor is actively transported intra-axonally, probably in association with organelles (LDVs?). (5) The activation and/or transport of the permissive factor are controlled "upstream" of the varicosity; they depend on Ca2+ influx through channels insensitive to nifedipine (hence, not of L-type) but blocked by Cd2+ and apparently opened by slight depolarization of the resting membrane, in this respect behaving more as T- than N-type channels. (6) A high resting K+ efflux "upstream" of the varicosity restricts the availability of the permissive factor; it is the main mechanism maintaining the (economically necessary) low release probability. (7) Prejunctional agonists do not inhibit transmitter secretion by causing a conduction block or by reducing the action potential-induced Ca2+ influx into the varicosity itself, but by depressing the Ca2(+)-dependent activation and/or transport of the permissive factor; they act at least in part via receptors "upstream" of the varicosity. (8) This hypothesis for regulation of the release probability in sympathetic nerves may apply, at least in part, to other neurons as well.

ATP as a sympathetic co-transmitter in rat vasomotor nerves--further evidence that individual release sites respond to nerve impulses by intermittent release of single quanta

A combination of intra- and extracellular recording was used to study neurotransmitter release in sympathetic vasomotor fibres in rat femoral and mesenteric arteries. The results show that neurotransmission in these preparations is similar to that in the 'short' sympathetic nerves in guinea-pig vas deferens and the 'long' sympathetic nerves in rat tail artery in the following respects: (1) The intracellularly recorded excitatory junction potentials (EJPs) and the extracellularly recorded junction currents (EJCs) presumably are caused by ATP secreted as a sympathetic co-transmitter. (2) The stimulus-evoked and spontaneous EJCs share the same brief time-course, which is similar to that of spontaneous EJPs, but much briefer than that of stimulus-evoked EJPs. (3) 'Successful' nerve impulses appear to release single transmitter quanta. (4) The probability of activation of individual release sites is low (0.002-0.02). (5) The low release probability cannot be accounted for by failure of the nerve impulse to invade the terminals. Moreover, it is also shown that application of tetrodotoxin to the medium within the recording electrode effectively abolishes transmitter secretion in the area enclosed by the tip of the electrode, indicating that the effective length constant for a passively propagating nerve action potential is probably very small and that activation of the release mechanisms in 'long' sympathetic nerve fibres seems to require that the varicosities are actively invaded.

Basic features of an extracellular recording method to study secretion of a sympathetic co-transmitter, presumably ATP

An extracellular recording method is described which permits in suitable model tissues (e.g. guinea-pig or mouse vas deferens) study of the nerve impulse in sympathetic terminals and the release of transmitter from sites inside or outside the recording electrode. Negative- or positive-going potentials were assumed to reflect the excitatory junction current (EJC) caused by transmitter released inside or outside the electrode, respectively, and hence termed 'EJCi' (i for inside) or 'EJCo' (o for outside). The EJCo were shown to be Ca2+-dependent, blocked by addition of tetrodotoxin or guanethidine, resistant to the alpha 1-adrenoceptor blocking agent prazosin but suppressed by desensitization of P2-purinoceptors by alpha,beta-methylene ATP, and hence, presumably, are caused by release of ATP as a sympathetic co-transmitter. The amplitude of the EJCo was voltage-dependent and increased with the length and frequency of stimulus trains within the range of 1-50 shocks at 0.1-2.5 Hz. In conclusion, combined use of EJCi and EJCo provides a useful tool for physiological and pharmacological analysis of pre- and post-junctional events associated with the secretion of a sympathetic co-transmitter, presumably ATP.